Schafer C Boeder

9PUBLICATIONS
14CO-AUTHORS
Information systems development methodologies and practiceMolecular targetsMedical biochemistry - carbohydratesPharmaceutical delivery technologiesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 08, 2025
Accuracy of Factory-Calibrated Continuous Glucose Monitors in Critically Ill Patients Receiving Intravenous Insulin: A Prospective Clinical Trial of Two Leading Systems.

Gautam Ramesh, Emily Kobayashi, Navyaa Sharma

|May 22, 2024
Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial.

Schafer C Boeder, Robert L Thomas, Melissa J Le Roux

|Mar 05, 2024
Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin.

Schafer Boeder, Michael J Davies, Janet B McGill

|Dec 15, 2022
Practical Guidance for Healthcare Providers on Collaborating with People with Type 2 Diabetes: Advancing Treatment and Initiating Injectable Therapy.

Schafer Boeder, David Matamoros, Caroline Mansy

|Oct 03, 2022
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.

Jeremy Pettus, Schafer C Boeder, Mark P Christiansen

|Dec 03, 2021
SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes.

Schafer C Boeder, Justin M Gregory, Erin R Giovannetti

Pageof 2

Frequent Collaborators

5 joint publications

Jeremy Pettus

3 joint publications

Justin M Gregory

3 joint publications

Robert L Thomas

2 joint publications

Timothy S Bailey